Therapeutic efficacy and tolerability of syrup based on natural active ingredients in the treatment of cough in children with an acute respiratory infection

Abstract

Introduction. Acute respiratory infections occupy the leading place in the structure of total infectious morbidity and account for more than 90% of all cases of infection. One of the most frequent clinical symptoms of acute respiratory infections is cough.Aim. To evaluate the therapeutic efficacy and tolerability of syrup based on active natural components in the treatment of cough in 2 to 7 years old children.Materials and methods. Patients 2 to 7 years old diagnosed with mild to moderate acute respiratory infections who had been coughing for no more than 3 days were included in the study.Results and discussion. We observed 123 children: 67 boys (54.5%) and 56 girls (45.5%). A statistically significant reduction in the severity of cough occurred on the 3rd day of treatment in both groups. On the 7th day of treatment, the degree of cough severity in both groups decreased on an average of 5 times. By the 7th day of taking the syrup, 97% of the children showed positive therapeutic effect: 55% of the patients’ cough symptoms resolved completely, 43% of the children had cough symptoms that became clinically insignificant. All these children recovered and were allowed to attend educational institutions. Reduction in the severity of cough when taking a syrup based on natural active components was accompanied by normalization of night sleep on average on the 4th day from the start of treatment.Conclusion. Receiving a syrup based on natural active ingredients in the early administration (within 3 days of coughing) for acute respiratory infections of mild and moderate severity allows 97% of children to cure a cough within 7 days.